726
Views
21
CrossRef citations to date
0
Altmetric
Review Article

Beryllium and lung cancer: A weight of evidence evaluation of the toxicological and epidemiological literature

, , , , , & show all
Pages 1-32 | Received 10 Nov 2008, Accepted 20 Feb 2009, Published online: 01 Apr 2009

References

  • ACGIH. 1996. Documentation of threshold limit values for beryllium and compounds. Cincinnati, OH: American Conference of Governmental Industrial Hygenists.
  • ACGIH. 2001. Documentation of threshold limit values for beryllium and compounds. Cincinnati, OH: American Conference of Governmental Industrial Hygenists.
  • ACGIH. 2008. Draft Documentation of threshold limit values for beryllium and compounds. Cincinnati, OH: American Conference of Governmen tal Industrial Hygenists.
  • Amand, W. B., W. H. Riser, and D. N. Biery. 1973. Spontaneous osteosarcoma with widespread meastasis in a belted dutch rabbit. J Am Anim Hosp Assoc 9:577–581.
  • Ames, B. N., and L. S. Gold. 1990. Chemical carcinogenesis: too many rodent carcinogens. Proc Natl Acad Sci USA 87(19):7772–7776.
  • Araki, M., S. Okada, and M. Fujita. 1954. Beryllium. Experimental studies on beryllium-induced malignant tumours of rabbits (Jpn.). Gann 45:449–451.
  • Ashby, J., M. Ishidate, Jr., G. D. Stoner, M. A. Morgan, F. Ratpan, and R. D. Callander. 1990. Studies on the genotoxicity of beryllium sulphate in vitro and in vivo. Mutat Res 240(3):217–225.
  • ATSDR. 2002. Toxicological profile for beryllium. Atlanta, GA: U.S. Department of Health and Human Services, Public Health Service, Agency for Toxic Substances and Disease Registry.
  • Axelson, O., and K. Steenland. 1988. Indirect mthods of assessing the effects of tobacco use in occupational studies. Am J Ind Med 13:105–118.
  • Barnes, J. M. 1950. Experimental production of malignant tumours by beryllium. Lancet 255:463.
  • Barnes, J. M., and F. A. Denz. 1950. Beryllium bone sarcomata in rabbits. Br J Cancer 4(2):212–222.
  • Bayliss, D. L. 1980. Letter to William H. Foege, M.D., Director, Center for Disease Control. Atlanta, GA.
  • Bayliss, D. L., W. S. Lainhart, L. J. Crally, R. Ligo, H. Ayer, and F. Hunter. 1971. Mortality patterns in a group of former beryllium workers. Paper read at thirty-third annual meeting of the American Conference of Governmental Industrial Hygienists, May 24–28, 1971, at Toronto, Canada.
  • BISAC (Beryllium Industry Scientific Advisory Committee). 1997. Is beryllium carcinogenic in humans? J Occup Environ Med 39(3):205–208.
  • Blair, A., K. Steenland, C. Shy, M. O’Berg, W. Halperin, and T. Thomas. 1988. Control of smoking in occupational epidemiologic studies: methods and needs. Am J Ind Med 13(1):3–4.
  • Borak, J. 2006. The beryllium occupational exposure limit: Historical origin and current inadequacy J Occup Environ Med 48:109–116.
  • Brown, C. C., and L. G. Kessler. 1988. Projections of lung cancer mortality in the United States: 1985-2025. J Natl Cancer Inst 80(1):43–51.
  • Brown, S. C., M. F. Schonbeck, D. McClure, A. E. Baron, W. C. Navidi, T. Byers, and A. J. Ruttenber. 2004. Lung cancer and internal lung doses among plutonium workers at the Rocky Flats Plant: A case-control study. Am J Epidemiol 160(2):163–172.
  • Browne, K. 1986. Is asbestos or asbestosis the cause of the increased risk of lung cancer in asbestos workers? Br J Ind Med 43:145–149.
  • Carpenter, A. V., W. D. Flanders, E. L. Frome, W. G. Tankersley, and S. A. Fry. 1988. Chemical exposures and central nervous system cancers: A case-control study among workers at two nuclear facilities. Am J Ind Med 13(3):351–362.
  • Checkoway, H., N. Pearce, and D. Kriebel. 2004. Research Methods in Occupational Epidemiology. 2nd ed. Vol. 34, Monographs in Epidemiology and Biostatistics. New York: Oxford University Press.
  • Checkoway, H., N. Pearce, J. L. Hickey, and J. M. Dement. 1990. Latency anal ysis in occupational epidemiology. Arch Environ Health 45(2): 95–100.
  • Chiba, I., T. Takahashi, M. M. Nau, D. D’Amico, D. T. Curiel, T. Mitsudomi, D. L. Buchhagen, D. Carbone, S. Piantadosi, H. Koga, et al. 1990. Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Lung Cancer Study Group. Oncogene 5(10):1603–10.
  • Cloudman, A. M., D. Vining, S. Barkulis, and J. J. Nickson. 1949. Bone changes observed following intravenous injection of beryllium. Am J Pathol 25:810–811.
  • Davies, J. M. 1984. Lung cancer mortality among workers making lead chromate and zinc chromate pigments at three English factories. Br J Ind Med 41:158–169.
  • Dean, A. G., K. M. Sullivan, and M. M. Soe. 2008. OpenEpi: Open Source Epidemiologic Statistics for Public Health, Version 2.2.1. Accessed 2008/11/08, www.OpenEpi.com.
  • Deubner, D. C., M. Goodman, and J. Iannuzzi. 2001. Variability, predictive value, and uses of the beryllium blood lymphocyte proliferation test (BLPT): Preliminary analysis of the ongoing workforce survey. Appl Occup Environ Hyg 16(5):521–526.
  • Deubner, D. C., J. L. Lockey, P. Kotin, M. B. Powers, F. Miller, A. E. Rogers, and D. Trichopoulos. 2001. Re: Lung cancer case-control study of beryllium workers. Sanderson WT, Ward EM, Steenland K, Petersen MR. Am. J. Ind. Med. 2001. 39:133–144. Am J Ind Med 40(3):284–288.
  • Deubner, D. C., Y. W. Lowney, D. J. Paustenbach, and J. Warmerdam. 2001. Contribution of incidental exposure pathways to total beryllium exposures. Appl Occup Environ Hyg 16(5):568–578.
  • Deubner, D. C., H. D. Roth, and P. S. Levy. 2007. Empirical evaluation of complex epidemiologic study designs: Workplace exposure and cancer. J Occup Environ Med 49(9):953–959.
  • Deubner, D., and M. Kent. 2007. Keeping beryllium workers safe: An enhanced preventive model. J Occup Environ Hyg 4(3):D23–30.
  • Deubner, D.C., and H.D. Roth. 2009. Rejoinder: Progress in understanding the relationship between beryllium exposure and lung cancer. Epidemiol 20. epub.
  • Doll, R., and J. Peto. 1985. Asbestos: Effects on health of exposure to asbestos: Health and Safety Commision.
  • Dutra, F. R., and E. J. Largent. 1950. Osteosarcoma induced by beryllium oxide. Am J Pathol 26(2):197–209.
  • Dutra, F. R., E. J. Largent, and J. L. Roth. 1951. Osteogenic sarcoma after inhalation of beryllium oxide. AMA Arch Pathol 51(5):473–479.
  • Eisenbud, M. 1993. Re: Lung cancer incidence among patients with berylllium disease. J Natl Cancer Inst 85:1697–1699.
  • Eisenbud, M. 1982. Origins of the standards for control of beryllium disease (1947–1949). Environ Res 27:79–88.
  • Eisenbud, M., and J. Lisson. 1983. Epidemiological aspects of beryllium-induced nonmalignant lung disease: A 30-year update. J Occup Med 25:196–202.
  • ESIS. 2008. Data sheet: Result for EC#: 231-150-7, European Inventory of Existing Commercial Chemical Substances. European Chemical Substances Information System.
  • Feingold, L., D. A. Savits, and E. M. John. 1992. Use of a job-exposure matrix to evaluate parental occupation and childhood cancer. Cancer Causes Control 3:161–169.
  • Finch, G.L., M.D. Hoover, F.F. Hahn, K.J. Nikula, S.A. Belinsky, P.J. Haley, and W.C. Griffith. 1996. Animal models of beryllium-induced lung disease. Environ Health Perspect 104(Suppl 5):973–979.
  • Fodor, I. 1977. Histogenesis of beryllium-induced bone tumours. Acta Morphol Acad Sci Hung 25(2–3):99–105.
  • Garabrant, D. H. 2007. Case-control study design: Spurious associations between exposure and outcome. J Occup Environ Med 49(9):941–942.
  • Gardener, L. U., and H. F. Heslington. 1946. Osteosarcoma from intravenous beryllium compounds in rabbits. Fed Proc 5:221.
  • Gazdar, A. F. 1990. Cell biology and molecular biology of small cell and non-small cell lung cancer. Curr Opin Oncol 2(2):321–327.
  • Gillies, P. A., B. Wilcox, C. Coates, F. Kristmundsdotir, and D. J. Reid. 1982. Use of objective measurement in the validation of self-reported smoking in children aged 10 and 11 years: Saliva thiocyanate. J Epid and Commun Health 36:205–208.
  • Gordon, T., and D. Bowser. 2003. Beryllium: Genotoxicity and carcinogenicity. Mutat Res 533(1–2):99–105.
  • Greenland, S. 1980. The effect of misclassification in the presence of covariates. Am J Epidemiol 112:564–569.
  • Greenland, S., and J. M. Robins. 1985. Confounding and misclassification. Am J Epidemiol 122:495–506.
  • Greim, H, ed. 2005. Beryllium and its compounds. Vol. 21, Occupational toxicants. Weinheim, Germany: Wiley-VCH.
  • Groth, D. H., C. Kommineni, and G. R. Mackay. 1980. Carcinogenicity of beryllium hydroxide and alloys. Environ Res 21(1):63–84.
  • Haley, P. J., G. L. Finch, M. D. Hoover, and R. G. Cuddihy. 1990. The acute toxicity of inhaled beryllium metal in rats. Fundam Appl Toxicol 15(4):767–778.
  • Hext, P. M. 1994. Current perspectives on particulate induced pulmonary tumours. Hum Exp Toxicol 13:700–715.
  • Hill, A. B. 1965. The environment and disease: Association or causation? Proc R Soc Med 58:295–300.
  • Hinds, M. W., L. N. Kolonel, and J. Lee. 1985. Application of a job-exposure matrix to a case-control study of lung cancer. J Natl Cancer Inst 75(2):193–197.
  • Hiruma, T. 1991. Rabbit osteosarcoma induced by hydroxypropylcellulose mixed beryllium oxide pellet—Comparison between implantations into bone marrow cavity and into fracture callus of the femur (Jpn.). Nippon Seikeigeka Gakkai Zasshi 65(9):775–786.
  • Hoagland, M. B., R. S. Grier, and M. B. Hood. 1950. Beryllium and growth. I. Beryllium-induced osteogenic sarcomata. Cancer Res 10(10): 629–635.
  • Hoover, J. P., D. B. Paulsen, C. W. Qualls, and R. J. Bahr. 1986. Osteogenic sarcoma with subcutaneous involvement in a rabbit. J Am Anim Hosp Assoc 9:1156–1158.
  • HSDB. 1997. Beryllium, elemental: Hazardous Substances Data Bank, National Institutes of Health. http://toxnet.nlm.nih.gov/cgi-bin/sis/search/f?./temp/~rreHS4:1. Accessed September 17, 2008.
  • HSE. 2006. Beryllium metal and beryllium compounds. In Disease reduction programme—Cancer project: Profiling of occupational carcinogens. Health and Safety Executive (HSE) Working Group on Action to Control Chemicals (WATCH), United Kingdom.
  • IARC. 1972. IARC monographs on the evaluation of carcinogenic risks of chemicals to man, Vol. 1: Some inorganic substances, chlorinated hydrocarbons, aromatic amines, N-nitroso compounds and natural products. Lyon, France: International Agency for Research on Cancer, World Health Organization.
  • IARC. 1980. IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans, Vol. 23: Some metals and metallic compounds. Lyon, France: International Agency for Research on Cancer, World Health Organization.
  • IARC. 1987. IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans, Suppl. 7: Overall evaluations of carcinogenicity: An updating of IARC monographs Volumes 1 to 42. Lyon, France: International Agency for Research on Cancer, World Health Organization.
  • IARC. 1992. IARC monographs on the evaluation of carcinogenic risks to humans, Vol. 54: Occupational exposures to mists and vapours from strong inorganic acids, and other industrial chemicals. Lyon, France: International Agency for Research on Cancer, World Health Organization.
  • IARC. 1993. IARC monographs on the evaluation of carcinogenic risks to humans, Vol. 58: Beryllium, cadmium, mercury, and exposures in the glass manufacturing industry. Lyon, France: International Agency for Research on Cancer, World Health Organization.
  • IARC. 2006. IARC monographs on the evaluation of carcinogenic risks to humans: Preamble. Lyon, France: International Agency for Research on Cancer, World Health Organization.
  • ILSI. 2000. The relevance of the rat lung response to particle overload for human risk assessment: A workshop consensus report. International Life Sciences Institute (ILSI) Risk Science Institute Workshop Participants. Inhal Toxicol 12:1–17.
  • Infante, P. F., J. K. Wagoner, and N. L. Sprince. 1980. Mortality patterns from lung cancer and nonneoplastic respiratory disease among white males in the beryllium case registry. Environ Res 21(1):35–43.
  • Ishinishi, N., M. Mizunoe, T. Inamasu, and A. Hisanaga. 1980. Experimental study on carcinogenicity of beryllium oxide and arsenic trioxide to the lung of rats by an intratracheal instillation (author’s transl, Jpn.). Fukuoka Igaku Zasshi 71(1):19–26.
  • Janes, J. M., G. M. Higgins, and J. F. Herrick. 1954. Beryllium-induced osteogenic sarcoma in rabbits. J Bone Joint Surg Br 36-B(4):543–552.
  • Jarvis, M. J., H. Tunstall-Pedoe, C. Feyerabend, C. J. Vesey, and Y. Saloojee. 1987. Comparison of tests used to distinguish smokers from nonsmokers. Am J Public Health 77:1435–1438.
  • Joseph, P., T. Muchnok, and T. Ong. 2001. Gene expression profile in BALB/c-3T3 cells transformed with beryllium sulfate. Mol Carcinogen 32(1):28–35.
  • Kahn, H. A. 1966. The Dorn study of smoking and mortality among U.S. veterans: Report on eight and one-half years of observation. Natl Cancer Inst Monograph 19:1–125.
  • Kelly, P. J., J. M. Janes, and L. F. Peterson. 1961. The effect of beryllium on bone. A morphological study of the progressive changes observed in rabbit bone. J Bone Joint Surg Am 43-A:829–844.
  • Keshava, N., G. Zhou, M. Spruill, M. Ensell, and T. M. Ong. 2001. Carcinogenic potential and genomic instability of beryllium sulphate in BALB/c-3T3 cells. Mol Cell Biochem 222(1–2):69–76.
  • Kolanz, M. E. 2001. Introduction to beryllium: Uses, regulatory history, and disease. Appl Occup Environ Hyg 16(5):559–567.
  • Kolstad, H. A., and J. Olsen. 1999. Why do short term workers have high mortality? Am J Epidemiol 149(4):347–352.
  • Komitowski, D. 1968. Experimental beryllium-induced bone tumours as a model of osteogenic sarcoma (Pol.). Chir Narzad Ruchu Ortop Pols 33:237–242.
  • Komitowski, D. 1974. Beryllium induced bone sarcomas (author’s transl, Ger.). Verh Dtsch Ges Pathol 58:438–440.
  • Kondo, H., M. Ishikawa, H. Maeda, M. Onuma, M. Masuda, H. Shibuya, H. Koie, and T. Sato. 2007. Spontaneous osteosarcoma in a rabbit (Orcytolagus cuniculus). Vet Pathol 44:691–694.
  • Kuroda, K., G. Endo, A. Okamoto, Y. S. Yoo, and S. Horiguchi. 1991. Genotoxicity of beryllium, gallium and antimony in short-term assays. Mutat Res 264(4):163–170.
  • Lamm, S. H., M. S. Levine, J. A. Starr, and S. L. Tirey. 1988. Analysis of excess lung cancer risk in short-term employees. Am J Epidemiol 127(6):1202–1209.
  • Laskin, S., R. A. N. Turner, and H. E. Stockinger, eds. 1950. An analysis of dust and fume hazards in a beryllium plant. Edited by A. Vorwald. Vol. Leroy U. Gardner Memorial: Pneuonoconiosis. New York: Hoeber.
  • Lavastre, V., C. J. Roberge, M. Pelletier, M. Gauthier, and D. Girard. 2002. Toxaphene, but not beryllium, induces human neutrophil chemotaxis and apoptosis via reactive oxygen species (ROS): Involvement of caspases and ROS in the degradation of cytoskeletal proteins. Clin Immunol 104(1):40–48.
  • Leffondre, K., M. Abrahamowicz, J. Siemiatycki, and B. Rachet. 2002. Modeling smoking history: A comparison of different approaches. Am J Epidemiol 156:813–823.
  • Leonard, A., and R. Lauwerys. 1987. Mutagenicity, carcinogenicity and teratogenicity of beryllium. Mutat Res 186(1):35–42.
  • Levy, P. S., H. D. Roth, and D. C. Deubner. 2007. Exposure to beryllium and occurrence of lung cancer: A reexamination of findings from a nested case-control study. J Occup Environ Med 49(1):96–101.
  • Levy, P. S., H. D. Roth, P. M. T. Hwang, and T. E. Powers. 2002. Beryllium and lung cancer: A reanalysis of a NIOSH cohort mortality study. Inhal Toxicol 14:1003–1015.
  • Litvinov, N. N., V. A. Popov, T. V. Vorozheikina, V. F. Kazenashev, and P. F. Bugryshev. 1983. Blastomogenic activities of various beryllium compounds (Russ.). Eksp Onkol 5:23–26.
  • Litvinov, N. N., V. A. Popov, T. V. Vorozheikina, V. F. Kazenashev, and P. F. Bugryshev. 1984. Data for more precise determination of the maximum allowable concentration of beryllium in the air of the workplace (Russ.). Gig Tr Prof Zabol 1:34–37.
  • MacMahon, B. 1994. The epidemiological evidence on the carcinogenicity of beryllium in humans. J Occup Med 36(1):15–26.
  • Madl, A. K., and K. E. Pinkerton. 2008. Health effects of inhaled engineered nanoscale materials. Edited by V. H. Grassian: Nanoscience and nanotechnology: Environmental and health impacts. Hoboken, NJ: John Wiley & Sons.
  • Mancuso, T. F. 1970. Relation of duration of employment and prior respiratory illness to respiratory cancer among beryllium workers. Environ Res 3(3):251–275.
  • Mancuso, T. F. 1980. Mortality study of beryllium industry workers’ occupational lung cancer. Environ Res 21(1):48–55.
  • Mancuso, T. F. 1979. Occupational lung cancer among beryllium workers. Paper read at Dusts and Disease, Society for Occupational and Envi ronmental Health Conference, at Park Forest, IL.
  • Mancuso, T. F., and A. A. El-Attar. 1969. Epidemiological study of the beryllium industry. Cohort methodology and mortality studies. J Occup Med 11(8):422–434.
  • Matsuura, K. 1974. Experimental studies on the production of osteosarcoma by beryllium compounds, and the effects of irradiation (Jpn.). Jpn J Orthop Assoc 48:403–418.
  • Mauderly, J. L. 1996. Lung overload: The dilemma and opportunities for resolution. Inhal Toxicol 8:1–28.
  • Mauderly, J. L., M. B. Snipes, E. B. Barr, S. A. Belinsky, J. A. Bond, A. L. Brooks, I. Y. Chang, Y. S. Cheng, N. A. Gillett, W. C. Griffith, et al. 1994. Pulmonary toxicity of inhaled diesel exhaust and carbon black in chronically exposed rats. Part 1: Neoplastic and nonneoplastic lung lesions. Res Rep Health Effects Inst 68:1–75; discussion 77–97.
  • Mazabraud, A. 1975. [Experimental production of bone sarcomas in the rabbit by a single local injection of beryllium]. Bull Cancer 62(1):49–58.
  • Mazzullo, G., M. Russo, P. P. Niiutta, and G. De Vico. 2004. Osteosrcoma with multiple metastases and subcutaneous involvement in a rabbit (Oryctolagus ciniculus). Vet Clin Path 33(2):102–104.
  • Monson, R. 1990. Case studies in occupational epidemiology. In Occupational Epidemiology, 2nd ed. Boca Raton, FL: CRC Press.
  • Morgareidge, K., G. E. Cox, and M. A. Gallo. 1976. Chronic feeding studies with beryllium in dogs. Food and Drug Research Laboratories, Inc. Submitted to the Aluminum Company of America, Alcan Research & Development, Ltd., Kawecki-Berylco Industries, Inc., and Brush-Wellman, Inc.
  • Nesnow, S., L. L. Triplett, and T. J. Slaga. 1985. Studies on the tumor initiating, tumor promoting, and tumor co-initiating properties of respiratory carcinogens. Carcinogenesis 8:257–277.
  • Nickell-Brady, C., F. F. Hahn, G. L. Finch, and S. A. Belinsky. 1994. Analysis of K-ras, p53 and c-raf-1 mutations in beryllium-induced rat lung tumors. Carcinogenesis 15(2):257–262.
  • Nikula, K. J., D. S. Swafford, M. D. Hoover, M. D. Tohulka, and G. L. Finch. 1997. Chronic granulomatous pneumonia and lymphocytic responses induced by inhaled beryllium metal in A/J and C3H/HeJ mice. Toxicol Pathol 25(1):2–12.
  • NIOSH. 2005. Pocket guide to chemical hazards, beryllium and beryllium compounds, DHEW (NIOSH) Publication No. 2005-151. Washington, DC: National Institute for Occupational Safety and Health.
  • NTP. 2005. Report on carcinogens, eleventh Edition: Beryllium and beryllium compounds: U.S. Department of Health and Human Services, Public Health Service, National Toxicology Program, Washington, DC.
  • OECD. 1997. Guidelines for the Testing of Chemicals. Organisation for Economic Co-operation and Development (OECD). Available at http://titania.sourceoecd.org/vl=3043871/cl=19/nw=1/rpsv/cw/vhosts/oecdjournals/1607310x/v1n4/contp1-1.htm.
  • Ohlson, C. G., and C. Hogstedt. 1985. Lung cancer among asbestos cement workers. A Swedish cohort study and review. Br J Ind Med 42:397–402.
  • OSHA. 1977. Informal standard for exposure to beryllium. Transcript of proceedings, August 31, 1977. Washington, DC: U.S. Department of Labor, Occupational Safety and Health Administration.
  • OSHA. 1989. OSHA Permissible Exposure Limits. 29 CFR 1910.1000, Table Z-1. Washington, DC: U.S. Department of Labor, Occupational Safety and Health Administration.
  • Paustenbach, D. J. 1989. Important recent advances in the practice of health risk assessment: implications for the 1990s. Regul Toxicol Pharmacol 10(3):204–243.
  • Peer Review Summary Report. 2008. Consolidated Comments from the External Peer Review Meeting on the Toxicological Review of Beryllium and Compounds (CAS No. 7440-41-7), Prepared for the U.S. EPA: Available at http://cfpub.epa.gov/ncea/cfm/recordisplay.cfm?deid=189634.
  • Pfeifer, A. M., G. E. Mark, 3rd, L. Malan-Shibley, S. Graziano, P. Amstad, and C. C. Harris. 1989. Cooperation of c-raf-1 and c-myc protooncogenes in the neoplastic transformation of simian virus 40 large tumor antigen-immortalized human bronchial epithelial cells. Proc Natl Acad Sci USA 86(24):10075–10079.
  • Rana, S. V. 2008. Metals and apoptosis: Recent developments. J Trace Elem Med Biol 22(4):262–284.
  • Reeves, A. L., D. Deitch, and A. J. Vorwald. 1967. Beryllium carcinogenesis. I. Inhalation exposure of rats to beryllium sulfate aerosol. Cancer Res 27(3):439–445.
  • Renfrew, H., and J. R. Rest. 2001. Extraskeletal fibroblastic osteosarcoma in a rabbit (Oryctolagus cuniculus). J Small Anim Pract 42:456–458.
  • Richiardi, L., F. Forastiere, P. Boffetta, L. Simonato, and F. Merletti. 2005. Effect of different approaches to treatment of smoking as a potential confounder in a case-control study on occupational exposures. Occup Environ Med 62:101–104.
  • Rossman, M. D., O. P. Preuss, and M. B. Powers, eds. 1991. Beryllium: Bio medical and environmental aspects. Baltimore, MD: Williams & Wilkins.
  • Rothman, K. J., S. Greenland, and T. L. Lash. 2008. Modern epidemiology, 3rd ed. Philadelphia, PA: Lippincott, Williams & Wilkins.
  • Salm, R., and J. Field. 1965. Osteosarcoma in a rabbit. J Pathol Bacteriol 89:400–402.
  • Sanderson, W. T. 2001c. Re: Response to criticisms of “Lung Cancer Case-Control Study of Beryllim Workers.” Am J Ind Med 40:286–288.
  • Sanderson, W. T., E. M. Ward, K. Steenland, and M. R. Petersen. 2001b. Lung cancer case-control study of beryllium workers. Am J Ind Med 39(2):133–144.
  • Sanderson, W. T., M. R. Peterson, and E. M. Ward. 2001a. Estimating historical exposures of workers in a beryllium manufacturing plant. Am J Ind Med 39:145–157.
  • Saracci, R. 1985. Interpretation of negative epidemiological evidence for carcinogenicity. IARC Sci Publ 65.
  • Schepers, G. W. 1961. Neoplasia experimentally induced by beryllium compounds. Prog Exp Tumor Res 2:203–244.
  • Schepers, G. W., F. T. Creedon, A. B. Delahant, and T. M. Durkan. 1957. The biological action of inhaled beryllium sulfate; a preliminary chronic toxicity study on rats. AMA Arch Ind Health 15(1):32–58.
  • Schroeder, H. A., and M. Mitchener. 1975. Life-term studies in rats: Effects of aluminum, barium, beryllium, and tungsten. J Nutr 105(4):421–427.
  • Schubauer-Berigan, M. K., J. A. Deddens, and M. R. Petersen. 2007. Re: exposure to beryllium and occurrence of lung cancer: A reexamination of findings from a nested case-control study. J Occup Environ Med 49(7):708–709; author reply 709–711.
  • Schubauer-Berigan, M. K., J. A. Deddens, K. Steenland, W. T. Sanderson, and M. R. Petersen. 2008. Adjustment for temporal confounders in a reanalysis of a case-control study of beryllium and lung cancer. Occup Environ Med 65(6):379–383.
  • Sivulka, D. J. 2006. Comparison of non neoplastic respiratory responses in animals after inhalation of water soluble and insoluble metal compounds: White paper available from Nickel Producers Environmental Research Association NiPERA, Toronto, Canada.
  • Sprince, N. L. 1986. Beryllium disease. In: Occupational Respiratory Diseases. Edited by J. Merchant, B. Boehlecke and G. Taylor. Washington, DC: U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, National Institute for Occupational Safety and Health.
  • Stayner, L., K. Steenland, M. Dosemeci, and I. Hertz-Picciotto. 2003. Attenuation of exposure-response curves in occupational cohort studies at high exposure levels. Scand J Work Environ Health 29(4):317–324.
  • Steenland, K., and E. Ward. 1991. Lung cancer incidence among patients with beryllium disease: A cohort mortality study. J Natl Cancer Inst 83(19):1380–1385.
  • Stewart, P. A., C. Schairer, and A. Blair. 1990. Comparison of jobs, exposures, and mortality risks or short-term and long-term workers. J Occup Med 32(8):703–708.
  • Stram, D. O., M. Huberman, and A. H. Hu. 2002. Is residual confounding a reasonable explanation for the apparent protective effects of beta-carotene found in epidemiologic studies of lung cancer in smokers? Am J Epidemiol 155:622–628.
  • Stulbarg, M. S., and L. Simmerman. 1996. Chronic obstructive pulmonary disease. In Occupational and Environmental Respiratory Diseases. Edited by P. Harber, M. Scheneker and J. Balmer. St. Louis, MO: Mosby.
  • Tapp, E. 1966. Beryllium induced sarcomas of the rabbit tibia. Br J Cancer 20(4):778–783.
  • Tapp, E. 1969. Osteogenic sarcoma in rabbits. Following subperiosteal implantation of beryllium. Arch Pathol 88(1):89–95.
  • Turton, J., and J. Hooson. 1998. Target organ pathology: A basic text. London: Taylor & Francis.
  • U.S. EPA. 1987. Health assessment document for beryllium. EPA/600/8-84 026F. Research Triangle Park, NC: U.S. Environmental Protection Agency.
  • U.S. EPA. 1991. Drinking water criteria document for beryllium. NTIS PB92-173301. Cincinnati, OH: Office of Health and Environmental Assessment, Environmental Criteria and Assessment Office for the Office of Drinking Water, U.S. Environmental Protection Agency.
  • U.S. EPA. 1998. Toxicological review of beryllium and compounds (CAS No. 7440-41-7), in supprt of summary information on the Integrated Risk Information System (IRIS). EPA/635/R-98/008. Washington, DC: U.S. Environmental Protection Agency.
  • U.S. EPA. 2005. Guidelines for Carcinogen Risk Assessment. EPA/630/P-03/001F. Washington, DC: U.S. Environmental Protection Agency.
  • U.S. EPA. 2008. IRIS toxicological review of beryllium (External review draft). EPA/635/R-08/009A. Washington, DC: U.S. Environmental Protection Agency.
  • U.S. Surgeon General. 1985. The health consequences of smoking. Cancer and chronic lung disease in the workplace. Rockville, MD: U.S. Department of Health and Human Services, Public Health Service.
  • Vacher, J., and H. B. Stoner. 1968. The transport of beryllium in rat blood. Biochem Pharmacol 17(1):93–107.
  • Vesey, C. J., Y. Saloojee, P. V. Cole, and M. A. H. Russell. 1982. Blood carboxyhaemoglobin, plasma thiocyanage, and cigarette consumption: Implications for epidemiological studies in smokers. Br J Med 284:1516–1518.
  • Vorwald, A. J. 1966. The induction of experimental pulmonary cancer in the primate. Paper read at Proc 9th Int Cancer Congress, Tokyo, Japan.
  • Wagner, W. D., D. H. Groth, J. L. Holtz, G. E. Madden, and H. E. Stokinger. 1969. Comparative chronic inhalation toxicity of beryllium ores, bertrandite and beryl, with production of pulmonary tumors by beryl. Toxicol Appl Pharmacol 15:10–29.
  • Wagoner, J. K., P. F. Infante, and D. L. Bayliss. 1980. Beryllium: An etiologic agent in the induction of lung cancer, nonneoplastic respiratory disease, and heart disease among industrially exposed workers. Environ Res 21(1):15–34.
  • Walberg, J. A. 1981. Osteogenic sarcoma with metastasis in a rabbit (Oryctolagus cuniculus). Lab Anim Sci 31(4):407–408.
  • Ward, E., A. Okun, A. Ruder, M. Fingerhut, and K. Steenland. 1992. A mortality study of workers at seven beryllium processing plants. Am J Ind Med 22(6):885–904.
  • Weisbroth, S. H., and A. Hurvits. 1969. Spontaneous osteogenic sarcoma in Oryctolagus cuniculus with elevated serum alkaline phosphatase. Lab Anim Care 19(2):263–265.
  • WHO. 2001. Beryllium and beryllium compounds. Geneva: Concise International Chemical Assessment Document 32, World Health Organization.
  • Yamaguchi, S. 1963. Study of beryllium-induced oseogenic sarcoma (Jpn.). Nagasaki Iggakai Zasshi 38:127–138.
  • Zorn, H., T. Stiefel, and H. Diem. 1977. Importance of beryllium and its compunds in occupational medicine. Part 2 (Ger.). Zbl. Arbeitsmed 27:83–88.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.